Evidence map›Paper›PMID 36610496›Full record

ArticleJournal of the American Society of Echocardiography : official publication of the American Society of Echocardiography2023

Complications Associated With Transesophageal Echocardiography in Transcatheter Structural Cardiac Interventions.

Ammar A Hasnie, Vibhu Parcha, Riem Hawi, Michael Trump, Naman S Shetty, Mustafa I Ahmed, Oscar J Booker, Pankaj Arora, Garima Arora

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Coming of Age: Facing Growing Pains in Structural Heart Interventions With Innovative Imaging Solutions.Journal of the Society for Cardiovascular Angiography & Interventions · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. 3D ICE-Guided T-TEER Performed by a Single Operator With Limited Imaging Support and Moderate Sedation.Journal of the Society for Cardiovascular Angiography & Interventions · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Transesophageal echocardiography related complications.Frontiers in cardiovascular medicine · 2024
    Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Ammar A HasnieDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Vibhu ParchaDivision of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama.
Riem HawiDivision of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama.
Michael TrumpDivision of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama.
Naman S ShettyDivision of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama.
Mustafa I AhmedDivision of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama.
Oscar J BookerDivision of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama.
Pankaj AroraDivision of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama; Section of Cardiology, Birmingham Veterans Affairs Medical Center, Birmingham, Alabama.
Garima AroraDivision of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama. Electronic address: garora@uabmc.edu.
University of Alabama at Birmingham · US

Funding

National Dissemination of I-Corps@NCATS: Accelerating Translation through CommercializationUL1TR003096 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GUTIERREZ, ORLANDO M, KIMBERLY, ROBERT P. · 2019 to 2023
$43.6M
Natriuretic Peptide-Renin-Angiotensin-Aldosterone System Rhythm Axis and Nocturnal Blood PressureR01HL160982 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Pankaj Arora · 2022 to 2026
$3.7M
Atrial Natriuretic Peptide and Regulation of Cardiometabolic Health: A Genotype-Guided Human Physiological StudyR01HL163081 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Pankaj Arora · 2022 to 2026
$3.7M
The Effects of Neprilysin Inhibition on Cardiometabolic Health in Black IndividualsR01HL163852 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Pankaj Arora · 2022 to 2026
$3.6M
Race, Natriuretic Peptides and Physiological PerturbationsK23HL146887 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ARORA, PANKAJ · 2019 to 2023
$969k
NCATS NIH HHS UL1 TR003096NHLBI NIH HHS K23 HL146887NHLBI NIH HHS R01 HL160982NHLBI NIH HHS R01 HL163081NHLBI NIH HHS R01 HL163852
6 · The paper itself

Abstract

backgroundTransesophageal echocardiograms (TEEs) performed during transcatheter structural cardiac interventions may result in greater complications than those performed in the nonoperative setting or even those performed during cardiac surgery. However, there are limited data on complications associated with TEE during these procedures. We evaluated the prevalence of major complications among these patients in the United States.

methodsA retrospective cohort study was conducted using an electronic health record database (TriNetX Research Network) from large academic medical centers across the United States for patients undergoing TEE during transcatheter structural interventions from January 2012 to January 2022. Using the American Society of Echocardiography-endorsed International Statistical Classification of Diseases and Related Health Problems Clinical Modifications (10th edition) codes, patients undergoing TEE during a transcatheter structural cardiac intervention, including transaortic, mitral or tricuspid valve repair, left atrial appendage occlusion, atrial septal defect closure, patent foramen ovale closure, and paravalvular leak repair, were identified. The primary outcome was major complications within 72 hours of the procedure (composite of bleeding and esophageal and upper respiratory tract injury). The secondary aim was the frequency of major complications, death, or cardiac arrest within 72 hours in patients who completed intraoperative TEE during surgical valve replacement.

resultsAmong 12,043 adult patients (mean age, 74 years old; 42% female) undergoing TEE for transcatheter structural cardiac interventions, 429 (3.6%) patients had a major complication. Complication frequency was higher in patients on anticoagulation or antiplatelet therapy compared with those not on therapy (3.9% vs 0.5%; risk ratio [RR] = 8.09, P < .001). Compared with those patients <65 years of age, patients ≥65 years of age had a higher frequency of major complications (3.9% vs 2.2%; RR = 1.75, P < .001). Complication frequency was similar among male and female patients (3.5% vs 3.7%; RR = 0.96, P = .67). Among 28,848 patients who completed surgical valve replacement with TEE guidance, 728 (2.5%) experienced a major complication.

conclusionsThis study found that more than 3% of patients undergoing TEE during transcatheter structural cardiac interventions have a major complication, which is more common among those on anticoagulant or antiplatelet therapy or who are elderly. With a shift of poor surgical candidates to less invasive percutaneous procedures, the future of TEE-guided procedures relies on comprehensive risk discussion and updating practices beyond conventional methods to minimize risk for TEE-related complications.

Indexed as

Echocardiography, TransesophagealHeart Septal Defects, AtrialAdultAgedCardiac CatheterizationEchocardiographyFemaleHeartHumansMalePlatelet Aggregation InhibitorsRetrospective StudiesTreatment OutcomePlatelet Aggregation InhibitorsOutcomesTranscatheter structural cardiac interventionsTransesophageal echocardiogramTransesophageal echocardiogram related complications

Identifiers

PMID36610496
PMCPMC10079559
OpenAlexW4313560099

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.